Skip to main content

Advertisement

Log in

A 2-year longitudinal study of bone health in adolescent patients with axial spondyloarthritis

  • Original Article
  • Published:
Archives of Osteoporosis Aims and scope Submit manuscript

Abstract

Purpose

Axial spondyloarthritis (axSpA) is a chronic inflammatory disease that primarily affects the axial skeleton and typically has an early onset. Although earlier onset is associated with worse prognosis, there have been few studies of bone mineral density (BMD) in adolescent patients with axSpA.

Methods

We analysed the clinical characteristics of 43 adolescent patients with axSpA at a baseline assessment and at a follow-up 2 years later. The baseline assessment included age, disease duration, treatment agents, and clinical, radiologic, and laboratory data. BMD of the lumbar spine, femoral neck, and total hip were measured by dual-energy X-ray absorptiometry during both the baseline assessment and the 2-year follow-up. We performed multivariate linear regression analyses to identify factors independently associated with BMD. We analysed the associations between changes in BMD and reductions in inflammatory markers.

Results

The average age of participants was 17.9 years and the mean disease duration was 2.2 years. Of the 43 patients, 10 (23%) had low BMD at any site (lumbar spine, femoral neck, and/or total hip). At baseline, multivariate analysis showed that body mass index (BMI), erythrocyte sedimentation rate (ESR), and spinal structural damage were associated with lumbar spine Z-scores. Increases in BMD in the lumbar spine were correlated with reductions in ESR (r = 0.40, P = 0.02) and C-reactive protein (CRP) (r = 0.40, P = 0.02). Increases in BMD in the total hip were correlated with reductions in CRP (r = 0.38, P = 0.03).

Conclusion

In adolescent axSpA patients, bone health was associated with systemic inflammation and the severity of structural damage. Reduced systemic inflammation was associated with improvements in bone health.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Weiss PF, Colbert RA (2018) Juvenile spondyloarthritis: a distinct form of juvenile arthritis. Pediatr Clin N Am 65:675–690

    Article  Google Scholar 

  2. Gmuca S, Weiss PF (2015) Juvenile spondyloarthritis. Curr Opin Rheumatol 27:364–372

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Bao J, Chen Y, Bao Y-X (2014) Prevalence and risk factors of low bone mineral density in juvenile onset ankylosing spondylitis. Calcif Tissue Int 95:108–111

    Article  CAS  PubMed  Google Scholar 

  4. Maillefert JF, Aho LS, El Maghraoui A, Dougados M, Roux C (2001) Changes in bone density in patients with ankylosing spondylitis: a two-year follow-up study. Osteoporos Int 12:605–609

    Article  CAS  PubMed  Google Scholar 

  5. Mitra D, Elvins DM, Collins AJ (1999) Biochemical markers of bone metabolism in mild ankylosing spondylitis and their relationship with bone mineral density and vertebral fractures. J Rheumatol 26:2201–2204

    CAS  PubMed  Google Scholar 

  6. Magrey M, Khan MA (2010) Osteoporosis in ankylosing spondylitis. Curr Rheumatol Rep 12:332–336

    Article  PubMed  Google Scholar 

  7. Kang KY, Kim IJ, Park S-H, Hong YS (2018) Associations between trabecular bone score and vertebral fractures in patients with axial spondyloarthritis. Rheumatology (Oxford) 57:1033–1040

    Article  Google Scholar 

  8. Thornton J, Pye SR, O’Neill TW, Rawlings D, Francis RM, Symmons DPM et al (2011) Bone health in adult men and women with a history of juvenile idiopathic arthritis. J Rheumatol 38:1689–1693

    Article  PubMed  Google Scholar 

  9. Kang KY, Chung MK, Kim HN, Hong YS, Ju JH, Park S-H (2018) Severity of sacroiliitis and erythrocyte sedimentation rate are associated with a low trabecular bone score in young male patients with ankylosing spondylitis. J Rheumatol 45:349–356

    Article  PubMed  Google Scholar 

  10. Rudwaleit M, Landewé R, van der Heijde D, Listing J, Brandt J, Braun J et al (2009) The development of Assessment of SpondyloArthritis International Society classification criteria for axial spondyloarthritis (part I): classification of paper patients by expert opinion including uncertainty appraisal. Ann Rheum Dis 68:770–776

    Article  CAS  PubMed  Google Scholar 

  11. Garrett S, Jenkinson T, Kennedy LG, Whitelock H, Gaisford P, Calin A (1994) A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol 21:2286–2291

    CAS  PubMed  Google Scholar 

  12. Calin A, Garrett S, Whitelock H, Kennedy LG, O’Hea J, Mallorie P et al (1994) A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index. J Rheumatol 21:2281–2285

    CAS  PubMed  Google Scholar 

  13. van der Heijde D, Lie E, Kvien TK, Sieper J, Van den Bosch F, Listing J et al (2009) ASDAS, a highly discriminatory ASAS-endorsed disease activity score in patients with ankylosing spondylitis. Ann Rheum Dis 68:1811–1818

    Article  PubMed  Google Scholar 

  14. Baim S, Leonard MB, Bianchi M-L, Hans DB, Kalkwarf HJ, Langman CB, Rauch F (2008) Official positions of the International Society for Clinical Densitometry and executive summary of the 2007 ISCD Pediatric Position Development Conference. J Clin Densitom 11:6–21

    Article  PubMed  Google Scholar 

  15. Averns HL, Oxtoby J, Taylor HG, Jones PW, Dziedzic K, Dawes PT (1996) Radiological outcome in ankylosing spondylitis: use of the Stoke Ankylosing Spondylitis Spine Score (SASSS). Br J Rheumatol 35:373–376

    Article  CAS  PubMed  Google Scholar 

  16. van der Linden S, Valkenburg HA, Cats A (1984) Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 27:361–368

    Article  PubMed  Google Scholar 

  17. Petty RE, Southwood TR, Manners P, Baum J, Glass DN, Goldenberg J, He X, Maldonado-Cocco J, Orozco-Alcala J, Prieur AM, Suarez-Almazor ME, Woo P, International League of Associations for Rheumatology (2004) International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol 31:390–392

    PubMed  Google Scholar 

  18. Gensler L, Davis JC (2006) Recognition and treatment of juvenile-onset spondyloarthritis. Curr Opin Rheumatol 18:507–511

    Article  PubMed  Google Scholar 

  19. Full Text PDF [Internet]. [cited 2020 Aug 31]. Available from: http://onlinelibrary.wiley.com.ssl.proxy.cuk.ac.kr:8080/doi/pdfdirect/10.1002/acr.22411

  20. Robinson Y, Sandén B, Olerud C (2013) Increased occurrence of spinal fractures related to ankylosing spondylitis: a prospective 22-year cohort study in 17,764 patients from a national registry in Sweden. Patient Saf Surg 7:2

    Article  PubMed  PubMed Central  Google Scholar 

  21. Kang KY, Kim IJ, Jung SM, Kwok S-K, Ju JH, Park K-S et al (2014) Incidence and predictors of morphometric vertebral fractures in patients with ankylosing spondylitis. Arthritis Res Ther 16:R124

    Article  PubMed  PubMed Central  Google Scholar 

  22. van der Weijden MAC, van Denderen JC, Lems WF, Heymans MW, Dijkmans BAC, van der Horst-Bruinsma IE (2011) Low bone mineral density is related to male gender and decreased functional capacity in early spondylarthropathies. Clin Rheumatol 30:497–503

    Article  PubMed  Google Scholar 

  23. Kang KY, Kwok S-K, Ju JH, Hong YS, Park S-H (2016) Assessment of fracture risk in patients with axial spondyloarthritis: a case–control study using the fifth Korean National Health and Nutrition Examination Survey (KNHANES V). Scand J Rheumatol. Taylor & Francis 45:23–31

    Article  CAS  PubMed  Google Scholar 

  24. Aydin T, Karacan I, Demir SE, Sahin Z (2005) Bone loss in males with ankylosing spondylitis: its relation to sex hormone levels. Clin Endocrinol 63:467–469

    Article  CAS  Google Scholar 

  25. Raisz LG (1988) Local and systemic factors in the pathogenesis of osteoporosis. N Engl J Med 318:818–828

    Article  CAS  PubMed  Google Scholar 

  26. Lange U, Teichmann J, Strunk J, Müller-Ladner U, Schmidt KL (2005) Association of 1.25 vitamin D3 deficiency, disease activity and low bone mass in ankylosing spondylitis. Osteoporos Int 16:1999–2004

    Article  CAS  PubMed  Google Scholar 

  27. Gratacós J, Collado A, Pons F, Osaba M, Sanmartí R, Roqué M et al (1999) Significant loss of bone mass in patients with early, active ankylosing spondylitis: a followup study. Arthritis Rheum 42:2319–2324

    Article  PubMed  Google Scholar 

  28. Kang KY, Lee KY, Kwok S-K, Ju JH, Park K-S, Hong YS, Kim HY, Park SH (2011) The change of bone mineral density according to treatment agents in patients with ankylosing spondylitis. Joint Bone Spine 78:188–193

    Article  CAS  PubMed  Google Scholar 

  29. Tang T, Tang X, Xu L, Huang Y, Zeng J, Li Q (2015) Evaluation of bone mass in children and young adults with juvenile idiopathic arthritis. Clin Exp Rheumatol 33:758–764

    PubMed  Google Scholar 

  30. Cimaz R (2002) Osteoporosis in childhood rheumatic diseases: prevention and therapy. Best Pract Res Clin Rheumatol 16:397–409

    Article  PubMed  Google Scholar 

  31. Cetin A, Celiker R, Dinçer F, Ariyürek M (1998) Bone mineral density in children with juvenile chronic arthritis. Clin Rheumatol 17:551–553

    Article  CAS  PubMed  Google Scholar 

  32. Kang KY, Ju JH, Park S-H, Kim H-Y (2013) The paradoxical effects of TNF inhibitors on bone mineral density and radiographic progression in patients with ankylosing spondylitis. Rheumatology. 52:718–726

    Article  CAS  PubMed  Google Scholar 

  33. Poddubnyy D, Hermann K-GA, Callhoff J, Listing J, Sieper J (2014) Ustekinumab for the treatment of patients with active ankylosing spondylitis: results of a 28-week, prospective, open-label, proof-of-concept study (TOPAS). Ann Rheum Dis 73:817–823

    Article  CAS  PubMed  Google Scholar 

  34. Baeten D, Baraliakos X, Braun J, Sieper J, Emery P, van der Heijde D, McInnes I, van Laar JM, Landewé R, Wordsworth P, Wollenhaupt J, Kellner H, Paramarta J, Wei J, Brachat A, Bek S, Laurent D, Li Y, Wang YA, Bertolino AP, Gsteiger S, Wright AM, Hueber W (2013) Anti-interleukin-17A monoclonal antibody secukinumab in treatment of ankylosing spondylitis: a randomised, double-blind, placebo-controlled trial. Lancet 382:1705–1713

    Article  CAS  PubMed  Google Scholar 

  35. Pathan E, Abraham S, Van Rossen E, Withrington R, Keat A, Charles PJ et al (2013) Efficacy and safety of apremilast, an oral phosphodiesterase 4 inhibitor, in ankylosing spondylitis. Ann Rheum Dis 72:1475–1480

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Kwi Young Kang.

Ethics declarations

Conflicts of interest

None.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kim, SH., Kim, K., Kim, MY. et al. A 2-year longitudinal study of bone health in adolescent patients with axial spondyloarthritis. Arch Osteoporos 16, 12 (2021). https://doi.org/10.1007/s11657-020-00860-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s11657-020-00860-y

Keywords

Navigation